Change - Announcement of Cessation::Cessation of Chairman of the Board - Dr Bernard Ng Kee Huat

Issuer & Securities

Issuer/ Manager
META HEALTH LIMITED
Securities
META HEALTH LIMITED - SG1O81915033 - 5DX
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
30-Apr-2024 00:06:31
Status
New
Announcement Sub Title
Cessation of Chairman of the Board - Dr Bernard Ng Kee Huat
Announcement Reference
SG240430OTHRQPEY
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Cessation of Dr Bernard Ng Kee Huat as the Chairman of the Board.

This announcement has been prepared by Meta Health Limited (the "Company") and its contents have been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor"), in accordance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr Alex Tan, Chief Executive Officer, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.

Additional Details

Name Of Person
Bernard Ng Kee Huat
Age
49
Is effective date of cessation known?
Yes
If yes, please provide the date
29/04/2024
Detailed Reason (s) for cessation
For good corporate governance, Dr Bernard Ng Kee Huat ("Dr Bernard Ng") has stepped down as the Chairman of the Board to separate the roles of the Chairman of the Board and the Chief Executive Officer of the Company to be held by separate persons.

For the avoidance of doubt, Dr Bernard Ng remains as an Executive Director and Group Chief Executive Officer.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
07/06/2022
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
1
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
5
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Group Chief Executive Officer.
Role and responsibilities
Executive, Responsible for the overall business strategy of the Group and the conduct of the Group's daily operational directions and decisions.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None.
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Direct Interest: 24,500,000 ordinary shares of the Company.
Past (for the last 5 years)
Gain Foods Pte. Ltd. (struck off)
Present
The Safe Space Foundation Ltd.
TS Medical (City Gate) Pte. Ltd.
Gainhealth Pte. Ltd.
MCE Technologies Holdings Pte. Ltd.
5Digital Pte. Ltd.